These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2221461)

  • 21. Current concepts: the use of heparin.
    Deykin D
    N Engl J Med; 1969 Apr; 280(17):937-8. PubMed ID: 5775632
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies of thrombosis following prostate operations (Preliminary report)].
    Sjögren S; Hedlund PO; Palmlöv A
    Nord Med; 1971 Oct; 86(40):1163-4. PubMed ID: 5131951
    [No Abstract]   [Full Text] [Related]  

  • 23. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 24. Small subcutaneous doses of heparin in prevention of venous thrombosis.
    Gallus AS; Hirsh J; Tutle RJ; Trebilcock R; O'Brien SE; Carroll JJ; Minden JH; Hudecki SM
    N Engl J Med; 1973 Mar; 288(11):545-51. PubMed ID: 4568221
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methods of heparin therapy in surgical patients with thrombohemorrhagic syndrome].
    Gasanov FD
    Anesteziol Reanimatol; 2012; (2):61-4. PubMed ID: 22834292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparinase-modified thrombelastometry: inactivation of heparin in plasma samples.
    Cvirn G; Tafeit E; Hoerl G; Janschitz M; Wagner T; Juergens G; Koestenberger M
    Clin Lab; 2010; 56(11-12):585-9. PubMed ID: 21141445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboembolic phenomena in clinical angiography: role of materials and technique.
    Dawson P; Strickland NH
    J Vasc Interv Radiol; 1991 Feb; 2(1):125-32. PubMed ID: 1799742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to avoid graft thrombosis requiring graftectomy: immediate posttransplant CT angiography in pancreas transplantation.
    Kim YH; Park JB; Lee SS; Byun JH; Kim SC; Han DJ
    Transplantation; 2012 Nov; 94(9):925-30. PubMed ID: 23034560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. II. A clinical study with the aid of intravenous phlebography.
    Becker J; Borgström S; Saltzman GF
    Acta Chir Scand; 1970; 136(3):167-71. PubMed ID: 4103355
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin.
    Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparinized saline to flush Groshong catheters.
    Horne MK; Mayo DJ; Wittes RE
    J Clin Oncol; 1993 Dec; 11(12):2458. PubMed ID: 8246036
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of arteriovenous shunt clotting.
    Modai D; Leiba IH; Alkan WJ
    JAMA; 1974 Oct; 230(3):427-30. PubMed ID: 4479264
    [No Abstract]   [Full Text] [Related]  

  • 34. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of thrombosis during pregnancy.
    Inbal A
    Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
    Krisper P; Tiran B; Fliser D; Haditsch B; Stadlbauer V; Otto R; Ernst T; Kretschmer U; Stauber RE; Haller H; Holzer H; Manns MP; Rifai K
    Artif Organs; 2010 Jan; 34(1):84-8. PubMed ID: 19663866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.
    Clifton GD; Branson P; Kelly HJ; Dotson LR; Record KE; Phillips BA; Thompson JR
    Heart Lung; 1991 Mar; 20(2):115-8. PubMed ID: 2004920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.